Treating Tobacco Use Disorder with Dr. David Mendez, MD

 
Tobacco use disorder
 
David Mendez MD
 
Objectives
 
Learn about nicotine withdrawal.
Discuss options for treatment of tobacco use disorder
Understand aspects of behavioral modification for
tobacco cessation
Learn about varenicline, bupropion, nicotine
replacement.
Briefly discuss e-cigarettes
 
Risks with
tobacco
 
Increase risk of MI and other coronary events
Heart failure
Stroke
Peripheral vascular disease
Malignancy (lung, head/neck, liver, pancreas, kidney,
bladder, uterine, leukemia)
COPD
Type 2 DM
Increased risk of infections
Osteoporosis
Wound healing
Up to one half of people who smoke expected to die from a
tobacco related illness
 
Nicotine
withdrawal
 
Cravings
Anger, irritability, frustration
Difficulties with concentration
Insomnia
Restlessness
Anxiety/depression
Increased appetite
 
Treatments
 
Behavioral modification
Varenicline
Bupropion
Nicotine replacement
 
Behavioral
Modification
 
Assess readiness to change:
5 A’s – Ask, Advise, Assess, Assist, Arrange
Assist:
Help formulate a quit plan
Identify triggers and areas of high risk use
Pharmacotherapy
Individual or group counseling effective
Brief counseling: education around withdrawal
symptoms, identify triggers for smoking, identify
coping skills to help with triggers, stress management
techniques
Telephone counseling via the quit line: 1800-QUIT-NOW
Texting: SmokeFree TXT program through National
Cancer institute
 
Varenicline
 
Binds with high affinity and partial agonism at nicotine
receptor
Patients quit one week after starting medication
Highest rate of success compared to nicotine
replacement or bupropion
Safe with co-morbid psychiatric diagnoses
Duration: at least 3 months. Can extend up to 1 year
Nightmares/vivid dreams
Consider removing evening dose
 
Nicotine
replacement
 
Can increase quit rates up to two fold compared to
placebo
Prescribe combo NRT (long and short acting)
Standard of care
Patch + gum/lozenge
Patch – 7, 14, 21mg doses
Provide sustained withdrawal relief x24 hours
Remove at bedtime
Gum/lozenge
As needed for control of breakthrough cravings
Can combine NRT with varenicline
Side effects: GI (N/V, abd pain), headache, local
irritation
Safe to use in patients with stable CVD
 
Nicotine
replacement
 
Patches
>10 cigs (1/2ppd): 21mg patch
<10 cigs: 14mg patch or less
Lower dosage as tolerated
Gum/lozenges
Park against buccal mucosa
Avoid acidic beverages (coffee, carbonated drinks)
Inhaler
Puff in short breaths and into back of throat (not into
lungs)
Helps with behavioral/sensory aspects of smoking
 
Bupropion
 
Mechanism: thought to increase noradrenergic and
dopamine release
2020 meta-analysis found rates of smoking cessation
higher compared to placebo
Dosing: bupropion SR 150mg BID
Start 1 week prior to quit date
Side effects: insomnia, agitation, dry mouth, headache
Contraindicated in patients with seizure disorder
Risk of seizures is dose dependent
 
Pregnancy
 
Placental abruption, PPROM, placenta previa, preterm
labor, low birth weight, ectopic pregnancy
Smoking cessation counseling is first line
Consider adding pharmacotherapy in addition to
counseling for individuals continuing to smoke
Add NRT or bupropion, starting at lowest dose possible
NRT appears to be safe, efficacy not established
Bupropion may be associated with small increase in
cardiac abnormalities
Avoid varenicline, limited data in pregnancy
 
E-cigarettes
 
Harm Reduction?
Tobacco not burned, could be safer
Unsure of long term side effects
Not FDA approved for smoking cessation
Slide Note
Embed
Share

Explore the risks associated with tobacco use disorder, learn about nicotine withdrawal, treatment options, and behavioral modifications for tobacco cessation. Discover the impact of tobacco on various health conditions and ways to break free from the addiction through pharmacotherapy, counseling, and support services. Enhance your knowledge on varenicline, bupropion, nicotine replacement, and the importance of assessing readiness for change.

  • Tobacco Use Disorder
  • Nicotine Withdrawal
  • Treatment Options
  • Behavioral Modification
  • Dr. David Mendez

Uploaded on Sep 11, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. Tobacco use disorder David Mendez MD

  2. Learn about nicotine withdrawal. Discuss options for treatment of tobacco use disorder Understand aspects of behavioral modification for tobacco cessation Objectives Learn about varenicline, bupropion, nicotine replacement. Briefly discuss e-cigarettes

  3. Increase risk of MI and other coronary events Heart failure Stroke Peripheral vascular disease Malignancy (lung, head/neck, liver, pancreas, kidney, bladder, uterine, leukemia) Risks with tobacco COPD Type 2 DM Increased risk of infections Osteoporosis Wound healing Up to one half of people who smoke expected to die from a tobacco related illness

  4. Cravings Anger, irritability, frustration Difficulties with concentration Nicotine withdrawal Insomnia Restlessness Anxiety/depression Increased appetite

  5. Behavioral modification Varenicline Treatments Bupropion Nicotine replacement

  6. Assess readiness to change: 5 A s Ask, Advise, Assess, Assist, Arrange Assist: Help formulate a quit plan Identify triggers and areas of high risk use Pharmacotherapy Behavioral Modification Individual or group counseling effective Brief counseling: education around withdrawal symptoms, identify triggers for smoking, identify coping skills to help with triggers, stress management techniques Telephone counseling via the quit line: 1800-QUIT-NOW Texting: SmokeFree TXT program through National Cancer institute

  7. Binds with high affinity and partial agonism at nicotine receptor Patients quit one week after starting medication Highest rate of success compared to nicotine replacement or bupropion Varenicline Safe with co-morbid psychiatric diagnoses Duration: at least 3 months. Can extend up to 1 year Nightmares/vivid dreams Consider removing evening dose

  8. Can increase quit rates up to two fold compared to placebo Prescribe combo NRT (long and short acting) Standard of care Patch + gum/lozenge Patch 7, 14, 21mg doses Provide sustained withdrawal relief x24 hours Remove at bedtime Nicotine replacement Gum/lozenge As needed for control of breakthrough cravings Can combine NRT with varenicline Side effects: GI (N/V, abd pain), headache, local irritation Safe to use in patients with stable CVD

  9. Patches >10 cigs (1/2ppd): 21mg patch <10 cigs: 14mg patch or less Lower dosage as tolerated Gum/lozenges Park against buccal mucosa Avoid acidic beverages (coffee, carbonated drinks) Nicotine replacement Inhaler Puff in short breaths and into back of throat (not into lungs) Helps with behavioral/sensory aspects of smoking

  10. Mechanism: thought to increase noradrenergic and dopamine release 2020 meta-analysis found rates of smoking cessation higher compared to placebo Dosing: bupropion SR 150mg BID Bupropion Start 1 week prior to quit date Side effects: insomnia, agitation, dry mouth, headache Contraindicated in patients with seizure disorder Risk of seizures is dose dependent

  11. Placental abruption, PPROM, placenta previa, preterm labor, low birth weight, ectopic pregnancy Smoking cessation counseling is first line Consider adding pharmacotherapy in addition to counseling for individuals continuing to smoke Pregnancy Add NRT or bupropion, starting at lowest dose possible NRT appears to be safe, efficacy not established Bupropion may be associated with small increase in cardiac abnormalities Avoid varenicline, limited data in pregnancy

  12. Harm Reduction? Tobacco not burned, could be safer E-cigarettes Unsure of long term side effects Not FDA approved for smoking cessation

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#